132
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma

, , , , , , , , & show all
Pages 119-129 | Published online: 22 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Anastasia Murtha-Lemekhova, Juri Fuchs, Erik Schulz, Anthe Suzan Sterkenburg, Philipp Mayer, Jan Pfeiffenberger & Katrin Hoffmann. (2021) Scirrhous Hepatocellular Carcinoma: Systematic Review and Pooled Data Analysis of Clinical, Radiological, and Histopathological Features. Journal of Hepatocellular Carcinoma 8, pages 1269-1279.
Read now

Articles from other publishers (10)

Dajana Glavas, Quoc Riccardo Bao, Marco Scarpa, Cesare Ruffolo, Zachary J. Brown, Timothy M. Pawlik & Gaya Spolverato. (2023) Treatment and Prognosis of Fibrolamellar Hepatocellular Carcinoma: a Systematic Review of the Recent Literature and Meta-analysis. Journal of Gastrointestinal Surgery 27:4, pages 705-715.
Crossref
Hassan Aziz, Zachary J Brown, Seyedeh Panid Madani, Ihab R Kamel & Timothy M Pawlik. (2022) Fibrolamellar Hepatocellular Carcinoma: Comprehensive Review of Diagnosis, Imaging, and Management. Journal of the American College of Surgeons 236:2, pages 399-410.
Crossref
Timothy A. Dinh, Alan F. Utria, Kevin C. Barry, Rosanna Ma, Ghassan K. Abou-Alfa, John D. Gordan, Elizabeth M. Jaffee, John D. Scott, Jessica Zucman-Rossi, Allison F. O’Neill, Mark E. Furth & Praveen Sethupathy. (2022) A framework for fibrolamellar carcinoma research and clinical trials. Nature Reviews Gastroenterology & Hepatology 19:5, pages 328-342.
Crossref
Xiaoyuan Chen, Yiwei Lu, Xiaoli Shi, Guoyong Han, Long Zhang, Chuangye Ni, Jie Zhao, Yun Gao & Xuehao Wang. (2022) Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma. Frontiers in Oncology 12.
Crossref
Maria G. Fencer, Catherine H. Davis, Jieqi Liu, Mark A. Galan & Kristen R. Spencer. (2022) Disease Control Achieved Using Atezolizumab + Bevacizumab in a Patient With Sarcomatoid Hepatocellular Carcinoma (SHCC), a Rare Variant Excluded From the IMbrave150 Trial. Journal of Investigative Medicine High Impact Case Reports 10, pages 232470962211294.
Crossref
Numbereye Numbere, Dongwei Zhang & Diana Agostini-Vulaj. (2021) A rare histologic subtype of hepatocellular carcinoma, sarcomatoid hepatocellular carcinoma: report of a case. Hepatic Oncology 8:2.
Crossref
Lorenza Rimassa, Nicola Personeni, Carolin Czauderna, Friedrich Foerster & Peter Galle. (2021) Systemic treatment of HCC in special populations. Journal of Hepatology 74:4, pages 931-943.
Crossref
Leigh Anne Dageforde, Neeta Vachharajani, Parissa Tabrizian, Vatche Agopian, Karim Halazun, Erin Maynard, Kristopher Croome, David Nagorney, Johnny C. Hong, David Lee, Cristina Ferrone, Erin Baker, William Jarnagin, Alan Hemming, Gabriel Schnickel, Shoko Kimura, Ronald Busuttil, Jessica Lindemann, Sander Florman, Matthew L. Holzner, Rami Srouji, Marc Najjar, Lavanya Yohanathan, Jane Cheng, Hiral Amin, Charles A. Rickert, Ju Dong Yang, Joohyun Kim, Jennifer Pasko, William C. Chapman & Maria B. Majella Doyle. (2021) Multi-Center Analysis of Liver Transplantation for Combined Hepatocellular Carcinoma-Cholangiocarcinoma Liver Tumors. Journal of the American College of Surgeons 232:4, pages 361-371.
Crossref
Abid M Sadiq, Minael G Mjemmas, Adnan M Sadiq & Gilbert Z Nkya. (2021) Sarcomatoid hepatocellular carcinoma in a young African female. SAGE Open Medical Case Reports 9, pages 2050313X2110524.
Crossref
Shalini Thapar Laroia, Komal Yadav, Archana Rastogi, Guresh Kumar, Senthil Kumar & Shiv Kumar Sarin. (2020) Diagnostic efficacy of dynamic liver imaging using qualitative diagnostic algorithm versus LI-RADS v2018 lexicon for atypical versus classical HCC lesions: A decade of experience from a tertiary liver institute. European Journal of Radiology Open 7, pages 100219.
Crossref